Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Hair loss is significantly linked to symptoms like dry hair, scalp issues, addiction to tobacco or coffee, anxiety, and digestive problems.

The study found that diseases can be grouped by symptoms and that the accuracy of predicting disease-related genes varies with the data source.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The lncRNA LOXL1-AS1 may help diagnose and treat androgenic alopecia.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

Researchers found four genes that could help diagnose severe alopecia areata early.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Finger length ratios don't predict baldness in men.

Women with PCOS have different levels of certain metabolites in their blood, which could help diagnose and predict the condition.

Autophagy prevents early aging and maintains lipid and pheromone balance in mouse glands.

hsa_circ_0001079 may help diagnose and treat hair loss.

The conclusion is that a new method can measure caffeine and drugs in hair, finding caffeine abusers have 70 times more caffeine than normal, with a proposed cut-off value for abuse.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Minoxidil activation by hair enzymes predicts treatment success for female hair loss.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.